+499.5%
MRNA vs FLNC
+53.3%
+446.1%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | FLNC | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | +1.5% | -3.7% | -2.5% |
| 7D | +5.5% | -4.9% | +10.3% | +6.2% |
| 30D | +158.7% | -27.3% | +186.0% | +171.6% |
| 3M | +182.1% | -61.9% | +244.0% | +215.8% |
| 6M | +151.8% | -34.5% | +186.3% | +157.1% |
| YTD | +393.6% | -47.7% | +441.2% | +409.6% |
| 1Y | +499.5% | +53.3% | +446.1% | +416.8% |
| All | +499.5% | +53.3% | +446.1% | +416.8% |
Cumulative growth
Daily Returns
Daily percentage return beside FLNC.
Daily Out/Under-Performance
Portfolio return minus FLNC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × FLNC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded FLNC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling